Clinical Trials Browser

INDUSTRY × Has results × eflapegrastim × Clear all

NCT01724866 2022-04-15

Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer

Phase 2 Completed

148 enrolled 45 charts

Neutropenia

NCT02643420 2022-03-02

ADVANCE

Phase 3 Completed

406 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT02953340 2022-03-02

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

Phase 3 Completed

237 enrolled 18 charts

Breast Neoplasms, Neutropenia